Image (70fc6598 0591 4201 83d4 01fa12f806e3 01)
Meclizine Hydrochloride Tablet
Product Images NDC 67296-2138
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 67296-2138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (70fc6598 0591 4201 83d4 01fa12f806e3 02)
This is a description of a medication tablet containing 12.5 mg of mecizine dihydrochloride, equivalent to 10.53 mg of mecizine base. The usual dosage varies and should be adjusted based on the clinical response of the patient. The tablets should be stored at 20° to 25°C (68° to 77°F) and kept out of reach of children since the package is child-resistant. The medication is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India.*
Label (70fc6598 0591 4201 83d4 01fa12f806e3 03)
This text appears to be a label on a medication package. The label includes information about the tablet, its ingredients, dosage, NDC number, manufacturer's details (Zydus Lifesciences Ltd., Ahmedabad, India), and instructions for use. It mentions the drug's availability in 100 tablets and the child-resistant packaging. The tablet contains 25 mg of meclizine hydrochloride and has different dosage instructions depending on the clinical response. It advises keeping the medication out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
